Novartis Pharmaceuticals Corporation

Form 483

East Hanover, New Jersey, United StatesFEI 2210396Issued April 24, 2009

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2210396.

Observations1

Issue DateApril 24, 2009

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Novartis Pharmaceuticals Corporation
Location: East Hanover, New Jersey, United States
FEI Number: 2210396
Product Type: Drugs
Issue Date: April 24, 2009
Country: United States

Inspection History, 2021 to 2026

NAI9

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Novartis Pharmaceuticals Corporation FDA Form 483, East Hanover, New Jersey, April 24, 2009